Menu Search
Equities

China NT Pharma Group Company Ltd

1011:HKG.HS

China NT Pharma Group Company Ltd

Actions
  • Price (HKD)0.023
  • Today's Change0.001 / 4.55%
  • Shares traded6.72m
  • 1 Year change-58.93%
  • Beta--
Data delayed at least 15 minutes, as of Jun 14 2024.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China NT Pharma Group Company Ltd is an investment holding company principally engaged in the research and development, production and sales of pharmaceutical products. The Company mainly provides development, distribution and agency services for sales of proprietary pharmaceutical products. The Company operates its bone health digital medicine platform by providing customized health package including bone health products, equipment and rehabilitation products. In addition, the Company engages in the investment in drugs and pharmaceutical companies’ equity as well as provision of marketing and promotion services to suppliers.

  • Revenue in HKD (TTM)7.93m
  • Net income in HKD-36.07m
  • Incorporated2010
  • Employees16.00
  • Location
    China NT Pharma Group Company LtdNo. 1 Hualing StreetSuzhou Industrial ParkSUZHOU 200020Hong KongHKG
  • Phone+852 28081606
  • Fax+852 25089459
  • Websitehttp://www.ntpharma.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.